| FGDMX | PRMTX | FGDMX / PRMTX | |
| Total Expense Ratio | 0.96 | 0.77 | 125% |
| Annual Report Gross Expense Ratio | 0.96 | 0.80 | 120% |
| Fund Existence | 7 years | 32 years | - |
| Gain YTD | 28.483 | 9.106 | 313% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | 1000 | - |
| Net Assets | 2.63B | 9.96B | 26% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 26.54 | 1.47 | 1,811% |
| Returns for 3 years | 141.56 | 46.86 | 302% |
| Returns for 5 years | 79.17 | -6.14 | -1,290% |
| Returns for 10 years | N/A | 132.88 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYMDX | 137.62 | 0.69 | +0.50% |
| Rydex Mid-Cap 1.5x Strategy H | |||
| MIEGX | 13.14 | 0.05 | +0.38% |
| BNY Mellon Emerging Markets Inv | |||
| RMGSX | 12.06 | 0.02 | +0.17% |
| Russell Inv Multi-Asset Strat S | |||
| DMCFX | 30.83 | 0.01 | +0.03% |
| Invesco Discovery Mid Cap Growth R5 | |||
| MUSEX | 42.01 | 0.01 | +0.02% |
| MFS Blended Research Core Equity I | |||